DEXLIQ 4 mg/ml, oral solution bottle, 30 ml
Active ingredients: Dexamethasone, Dexamethasone sodium phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 30 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DEXLIQ 4 mg/mL, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon jaune (brun) de 30 ml avec fermeture de sécurité enfant avec adaptateur polyéthylène basse densité (PEBD) avec seringue(s) pour administration orale polyéthylène basse densité (PEBD)
- Marketing authorisation holder
- THERAVIA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 May 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67756414CIP73013344CIP133400930133446Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DEXAMÉTHASONEsolution | 4 mg · 1 ml de solution | FT |
| PHOSPHATE SODIQUE DE DEXAMÉTHASONEsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.